Weiguang Biotechnology: Announcement of Resolutions of the Eleventh Meeting of the Fourth Board of Directors
Securities code: 002880 Securities abbreviation: Weiguang Biology Announcement number: 2026-029
Shenzhen Weiguang Biological Products Co., Ltd.
Announcement of Resolutions of the Eleventh Meeting of the Fourth Board of Directors
The company and all members of the board of directors guarantee that the information disclosed is true, accurate and complete, and contains no false records, misleading statements or major omissions.
1. Convening of board of directors meetings
The 11th meeting of the fourth board of directors of Shenzhen Weiguang Biological Products Co., Ltd. (hereinafter referred to as the company) was held on July 14, 2026 in the conference room on the 4th floor of the company's office building through on-site and communication methods. Nine directors were supposed to attend this meeting, but actually nine directors attended. The company's senior managers also attended the meeting. This meeting was chaired by Mr. Zhang Zhan, Chairman of the Board. The convening, holding and voting procedures of the meeting complied with the provisions of the Company Law and other relevant laws, regulations and the Articles of Association.
2. Review status of board of directors meeting
After deliberation item by item and written voting, the meeting reviewed and approved the following proposals:
- The "Proposal on Extending the Validity Period of the Shareholders' Meeting Resolution on the Company's Issuance of A Shares to Specific Targets in 2025" was reviewed and approved;
After deliberation, the board of directors agreed to extend the validity period of the company's shareholders' meeting resolution to issue A shares to specific objects in 2025 for 12 months from the expiration date of the original validity period. In addition to extending the validity period, the company's plan to issue A shares to specific targets remains unchanged. For details, please refer to the "Announcement on Extending the Validity Period of the Company's Shareholders' Meeting Resolution on Issuing A Shares to Specific Targets in 2025 and the Validity Period of Related Authorizations" published on the designated information disclosure media and the cninfo.com (www.cninfo.com.cn) on the same day.
Voting results: 9 votes in favor, 0 votes against, and 0 abstentions.
This proposal still needs to be reviewed and approved by the company's shareholders' meeting.
- Considered and approved the "Proposal on Requesting the Shareholders' Meeting to Extend the Validity Period of Authorizing the Board of Directors or Persons Authorized by the Board of Directors to Have Full Power to Handle Matters Related to the Issuance of A Shares to Specific Targets";
After deliberation and approval, the board of directors proposed that the shareholders' meeting authorize the board of directors or persons authorized by the board of directors to have full authority to handle matters related to the company's issuance of A shares to specific objects in 2025. The validity period will be extended by 12 months from the expiration date of the original validity period. For details, please refer to the "Announcement on Extending the Validity Period of the Company's Shareholders' Meeting Resolution on Issuing A Shares to Specific Targets in 2025 and the Validity Period of Related Authorizations" published on the designated information disclosure media and the cninfo.com (www.cninfo.com.cn) on the same day.
Voting results: 9 votes in favor, 0 votes against, and 0 abstentions.
This proposal still needs to be reviewed and approved by the company's shareholders' meeting.
- Reviewed and approved the "Proposal on Applying for Special Loans from Banks";
In order to ensure the capital needs for the construction of the company's intelligent industrial base project, the board of directors approved after review the company's application for a special loan from the bank. The loan period is 36 months and the loan amount does not exceed RMB 200 million (inclusive). The specific amount shall be subject to the actual withdrawal amount. The loan is used for the construction of the company's intelligent industrial base project. The loan interest rate is determined according to the lower limit of the inter-bank market interest rate pricing self-regulatory mechanism, which is not higher than 2.34%. This loan is raised through the cooperation of multiple banks. The specific cooperative bank shall be subject to the final signed agreement.
Voting results: 9 votes in favor, 0 votes against, and 0 abstentions.
- Reviewed and approved the "Proposal on the Appointment of Senior Management Personnel";
After being reviewed and approved by the Nomination Committee, this proposal will be submitted to the Board of Directors for review.
After deliberation, the board of directors approved the appointment of Ms. Wang Xueyun and Mr. Yang Mingze as deputy general managers of the company, with their terms starting from the date of review and approval by the board of directors and ending on the expiration date of the fourth session of the board of directors. For details, please refer to the "Announcement on the Appointment of Senior Management Personnel" published on the designated information disclosure media and the cninfo website (www.cninfo.com.cn) on the same day.
Voting results: 9 votes in favor, 0 votes against, and 0 abstentions.
- The "Proposal on Convening the First Extraordinary Shareholders' Meeting in 2026" was reviewed and approved.
After deliberation, the board of directors agreed to hold the first extraordinary shareholders' meeting of 2026 on July 31, 2026 in the conference room on the 4th floor of the company's office building. For details, please refer to the "Notice on Convening the First Extraordinary Shareholders Meeting in 2026" published on the designated information disclosure media and the cninfo website (www.cninfo.com.cn) on the same day.
Voting results: 9 votes in favor, 0 votes against, and 0 abstentions.
3. Documents for reference
Resolution of the 11th meeting of the 4th Board of Directors;
Resolution of the first meeting of the Nomination Committee of the Fourth Board of Directors in 2026.
Announcement is hereby made.
Board of Directors of Shenzhen Weiguang Biological Products Co., Ltd.
July 15, 2026